These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25502724)

  • 1. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.
    Ganna A; Salihovic S; Sundström J; Broeckling CD; Hedman AK; Magnusson PK; Pedersen NL; Larsson A; Siegbahn A; Zilmer M; Prenni J; Arnlöv J; Lind L; Fall T; Ingelsson E
    PLoS Genet; 2014 Dec; 10(12):e1004801. PubMed ID: 25502724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Non-Targeted Liquid Chromatographic-Mass Spectrometric Metabolomics Approach for Association with Coronary Artery Disease: An Identification of Biomarkers for Depiction of Underlying Biological Mechanisms.
    Zhang XZ; Zheng SX; Hou YM
    Med Sci Monit; 2017 Feb; 23():613-622. PubMed ID: 28151921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus genetic risk scores for coronary heart disease prediction.
    Ganna A; Magnusson PK; Pedersen NL; de Faire U; Reilly M; Arnlöv J; Sundström J; Hamsten A; Ingelsson E
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2267-72. PubMed ID: 23685553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort.
    Daka B; Olausson J; Larsson CA; Hellgren MI; Råstam L; Jansson PA; Lindblad U
    BMC Cardiovasc Disord; 2015 Nov; 15():146. PubMed ID: 26573599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolomic profile is associated with the risk of incident coronary heart disease.
    Vaarhorst AA; Verhoeven A; Weller CM; Böhringer S; Göraler S; Meissner A; Deelder AM; Henneman P; Gorgels AP; van den Brandt PA; Schouten LJ; van Greevenbroek MM; Merry AH; Verschuren WM; van den Maagdenberg AM; van Dijk KW; Isaacs A; Boomsma D; Oostra BA; van Duijn CM; Jukema JW; Boer JM; Feskens E; Heijmans BT; Slagboom PE
    Am Heart J; 2014 Jul; 168(1):45-52.e7. PubMed ID: 24952859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations.
    Deng K; Gupta DK; Shu XO; Lipworth L; Zheng W; Cai H; Cai Q; Yu D
    Circ Genom Precis Med; 2024 Aug; 17(4):e004437. PubMed ID: 38950084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study.
    Zhuang Q; Shen C; Chen Y; Zhao X; Wei P; Sun J; Ji Y; Chen X; Yang S
    BMC Med Genet; 2019 Nov; 20(1):170. PubMed ID: 31694563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and serum creatinine, but not haemoglobin A1c, are independent predictors of coronary heart disease risk in non-diabetic Chinese.
    Salim A; Tai ES; Tan VY; Welsh AH; Liew R; Naidoo N; Wu Y; Yuan JM; Koh WP; van Dam RM
    Eur J Prev Cardiol; 2016 Aug; 23(12):1339-49. PubMed ID: 26780920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke.
    Lind L; Salihovic S; Ganna A; Sundström J; Broeckling CD; Magnusson PK; Pedersen NL; Siegbahn A; Prenni J; Fall T; Ingelsson E; Ärnlöv J
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104476. PubMed ID: 31806450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.
    Drenos F; Talmud PJ; Casas JP; Smeeth L; Palmen J; Humphries SE; Hingorani AD
    Hum Mol Genet; 2009 Jun; 18(12):2305-16. PubMed ID: 19336475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.
    Lakoski SG; Liu Y; Brosnihan KB; Herrington DM
    Atherosclerosis; 2008 Mar; 197(1):443-7. PubMed ID: 17706223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the value of a genetic risk score in improving the estimation of coronary risk.
    Lluis-Ganella C; Subirana I; Lucas G; Tomás M; Muñoz D; Sentí M; Salas E; Sala J; Ramos R; Ordovas JM; Marrugat J; Elosua R
    Atherosclerosis; 2012 Jun; 222(2):456-63. PubMed ID: 22521901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population.
    Stenemo M; Ganna A; Salihovic S; Nowak C; Sundström J; Giedraitis V; Broeckling CD; Prenni JE; Svensson P; Magnusson PKE; Lind L; Ingelsson E; Ärnlöv J; Fall T
    ESC Heart Fail; 2019 Aug; 6(4):764-773. PubMed ID: 31148414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study.
    de Vries PS; Kavousi M; Ligthart S; Uitterlinden AG; Hofman A; Franco OH; Dehghan A
    Int J Epidemiol; 2015 Apr; 44(2):682-8. PubMed ID: 25953786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics identified novel cholesterol-independent predictors for risk of incident coronary heart disease: Mediation of risk from diabetes and aggravation of risk by ambient air pollution.
    Li Y; Wang H; Xiao Y; Yang H; Wang S; Liu L; Cai H; Zhang X; Tang H; Wu T; Qiu G
    J Adv Res; 2024 Nov; 65():273-282. PubMed ID: 38104795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
    Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EN-RAGE: a novel inflammatory marker for incident coronary heart disease.
    Ligthart S; Sedaghat S; Ikram MA; Hofman A; Franco OH; Dehghan A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2695-9. PubMed ID: 25341801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.